Trial record 71 of 1238 for:    "Observational" [STUDY-TYPES] AND HIV [CONDITION]

Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00433030
Recruitment Status : Completed
First Posted : February 9, 2007
Last Update Posted : March 20, 2018
Global Fund
Ministry of Health, Thailand
Information provided by (Responsible Party):
GONZAGUE JOURDAIN, Institut de Recherche pour le Developpement

Brief Summary:

Since 2004, the Thai Ministry of Public Health has massively scaled up antiretroviral treatment programs to provide therapy to more than 80,000 patients with partial support of the Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM).

As access to HIV care continues to expand under the universal health coverage system, it is important to document and analyze the efficacy, tolerance, toxicity and acceptability of antiretroviral therapy within pilot treatment programs, to provide evidence based feedback and recommendations to the national program and policy makers.

Condition or disease
HIV Infections

Detailed Description:

As Thailand is rapidly expanding access to antiretroviral treatments under the universal health coverage system, it is crucial to document and learn from pilot antiretroviral treatment programs, in particular the medical outcomes and logistical, and organizational issues faced by hospital teams and patients in order to adapt the ARV delivery and monitoring system to various local settings.

Specific objectives

  1. Analyze data collected in patients participating in the PHPT antiretroviral treatment program, in accordance to national and international guidelines, with no experimental interventions.
  2. To determine factors associated with treatment outcome including immune status, virologic factors and antiretroviral drugs levels
  3. To study the operational aspects of integrating comprehensive HIV care into the existing care system with regards to new activities generated at the hospital level (counseling, referral systems, biological monitoring), the impact on other health activities, mobilization of human and financial resources, affordability and sustainability.

The population of the study consists of approximately 2,000 consenting HIV-infected patients, including one-third of children, receiving HIV care as part of the GF-ATM or OXFAM Access to Antiretroviral programs, presenting at any of the PHPT network hospitals.

Study Type : Observational
Actual Enrollment : 2816 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand
Study Start Date : January 2007
Actual Primary Completion Date : February 2018
Actual Study Completion Date : February 2018

Resource links provided by the National Library of Medicine

Biospecimen Retention:   Samples With DNA
Blood samples

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
HIV-infected Adults and Children

Inclusion Criteria:

  • Adults and children (children are defined as less than 18 years old) patients are eligible for the inclusion in the cohort if they meet all the following inclusion criteria:

    • Participation in the GFATM or Oxfam Access to Antiretroviral Programs
    • For adults, consent to have their clinical or biological data used for this research study, and willingness to be followed at one of the PHPT network hospitals. For children, caregiver's consent to participate, willingness to bring the child to the scheduled visits for the duration of the treatment, and to have the child's clinical or biological data used for this research study.

Exclusion Criteria:

  • This is an observational study of an access to treatment program, therefore all patients who require treatment and are willing to be followed by the medical team and have their data collected can be enrolled in the study. The only exclusion criteria would be refusal to participate and the discontinuation criteria would be withdrawal of consent.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00433030

Doi Saket Hospital
Doi Saket, Chiang Mai, Thailand
Mae on Hospital
Mae on, Chiang Mai, Thailand
Nakornping Hospital
Mae Rim, Chiang Mai, Thailand
San Kamphaeng Hospital
San Kamphaeng, Chiang Mai, Thailand
Sanpatong Hospital
San Pa Tong, Chiang Mai, Thailand, 50120
San Sai Hospital
San Sai, Chiang Mai, Thailand
Mae Chan Hospital
Mae Chan, Chiang Rai, Thailand
Mae Sai Hospital
Mae Sai, Chiang Rai, Thailand
Phan Hospital
Phan, Chiang Rai, Thailand
Chiangrai Prachanukroh Hospital
Chiang Rai, Chiangrai, Thailand
Somdej Pranangchao Sirikit Hospital
Sattahip, Chonburi, Thailand
Kranuan Crown Prince Hospital
Kranuan, Khon Kaen, Thailand
Mahasarakam Hospital
Maha Sarakham, Mahasarakam, Thailand
Nakhonpathom Hospital
Nakhon Pathom, Nakhonpathom, Thailand
Chiang Kham Hospital
Chiang Kham, Phayao, Thailand
Hat Yai Hospital
Hat Yai, Songkla, Thailand
Bhumibol Adulyadej Hospital
Bangkok, Thailand
Nopparat Rajathanee Hospital
Bangkok, Thailand
Somdej Prapinklao Hospital
Bangkok, Thailand
Chacheongsao Hospital
Chachoengsao, Thailand
Prapokklao Hospital
Chanthaburi, Thailand
Chonburi Hospital
Chon Buri, Thailand
Kalasin Hospital
Kalasin, Thailand
Phaholpolphayuhasena Hospital
Kanchanaburi, Thailand
Khon Kaen Hospital
Khon Kaen, Thailand
Regional Health Promotion Centre 6, Khon Kaen
Khon Kaen, Thailand
Lampang Hospital
Lampang, Thailand
Lamphun Hospital
Lamphun, Thailand
Maharaj Nakornratchasrima Hospital
Nakhon Ratchasima, Thailand
Nong Khai Hospital
Nong Khai, Thailand
Pranangklao Hospital
Nonthaburi, Thailand
Phayao Provincial Hospital
Phayao, Thailand
Buddhachinaraj Hospital
Phitsanulok, Thailand
Ratchaburi Hospital
Ratchaburi, Thailand
Rayong Hospital
Rayong, Thailand
Roi-et Hospital
Roi-et, Thailand
Samutprakarn Hospital
Samut Prakan, Thailand
Samutsakon Hospital
Samut Sakhon, Thailand
Sponsors and Collaborators
Institut de Recherche pour le Developpement
Global Fund
Ministry of Health, Thailand
Principal Investigator: Gonzague JOURDAIN, MD, PhD Institut de Recherche pour le Developpement

Additional Information:
Publications of Results:
Tang MW, Rhee SY, Bertagnolio S, Ford N, Holmes S, Sigaloff KC, Hamers RL, de Wit TF, Fleury HJ, Kanki PJ, Ruxrungtham K, Hawkins CA, Wallis CL, Stevens W, van Zyl GU, Manosuthi W, Hosseinipour MC, Ngo-Giang-Huong N, Belec L, Peeters M, Aghokeng A, Bunupuradah T, Burda S, Cane P, Cappelli G, Charpentier C, Dagnra AY, Deshpande AK, El-Katib Z, Eshleman SH, Fokam J, Gody JC, Katzenstein D, Koyalta DD, Kumwenda JJ, Lallemant M, Lynen L, Marconi VC, Margot NA, Moussa S, Ndung'u T, Nyambi PN, Orrell C, Schapiro JM, Schuurman R, Sirivichayakul S, Smith D, Zolfo M, Jordan MR, Shafer RW. Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine. J Infect Dis. 2013 Jun 15;207 Suppl 2:S70-7. doi: 10.1093/infdis/jit114.

Responsible Party: GONZAGUE JOURDAIN, Senior Researcher, Institut de Recherche pour le Developpement Identifier: NCT00433030     History of Changes
Other Study ID Numbers: PHPT-Cohort
First Posted: February 9, 2007    Key Record Dates
Last Update Posted: March 20, 2018
Last Verified: March 2018

Keywords provided by GONZAGUE JOURDAIN, Institut de Recherche pour le Developpement:
Highly Active Antiretroviral Therapy
HIV Viral load
HIV drug Resistance

Additional relevant MeSH terms:
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases